| Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224) |
|---|
| 02/13/2007 | US7176242 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 02/13/2007 | US7176176 For floral/jasmine fragrances/flavorings |
| 02/08/2007 | WO2007016431A2 Novel benzo [d] [1,3]-dioxol derivatives |
| 02/08/2007 | WO2007014958A1 Process for the preparation of alkylene carbonates |
| 02/08/2007 | CA2617573A1 Process for the preparation of alkylene carbonates |
| 02/07/2007 | EP1749523A1 GSK-3 inhibitors |
| 02/07/2007 | CN1910126A Bicyclo[3.3.1]nonanes and bicyclo[3.3.1]nonenes and their use as flavour or fragrance ingredient |
| 02/07/2007 | CN1907981A Method for synthesizing isophorone derivative |
| 02/07/2007 | CN1907980A Method for synthesizing dihydrosafrole |
| 02/06/2007 | US7173148 1-acetoxy-2-methyl-3-(3,4-methylenedioxyphenyl)propene; alkylation of a benzene compound with alkenylidene diacetate in the presence of a catalyst halogenated boron compounds, triflate compounds, Group 12 halogenated compounds, triflate compounds and halogenated compounds of tin and lanthanoid elements |
| 02/06/2007 | US7173132 Certain substituted 1-aryl-3-piperazine-1′-yl propanones |
| 02/06/2007 | US7173019 Linked cyclitols and their polysulfated derivatives |
| 02/01/2007 | WO2007013201A1 Zinc fluorescent probe |
| 02/01/2007 | WO2007012641A1 Process for preparing 3,4-dioxo-substituted aromatic aldehydes |
| 02/01/2007 | US20070027185 inhibitor of factor Xa and/or thrombin; anticoagulantsto treat thromboembolic disorders, myocardial ischemia, myocardial infarction and cerebral thrombosis; N-(5-chloropyridin-2-yl)-3-[2-(piperidin-4-yloxy)-4-(pyrrolidin-1-yl)benzoylamino]pyridine-4-carboxamide; high bioavailability; acylation |
| 02/01/2007 | US20070027158 High affinity small molecule C5a receptor modulators |
| 02/01/2007 | US20070027060 2-methyl-4-pheny1-1,3-dioxolane |
| 01/31/2007 | CN1905881A Diamine and iminodiacetic acid hydroxamic acid derivatives |
| 01/31/2007 | CN1297546C Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same |
| 01/30/2007 | US7169907 Derivatives, immunogens, and antibodies for detecting ecstasy-class drugs |
| 01/30/2007 | US7169817 Treatment and/or prevention of diseases or disorders mediated by lymphocyte interactions. |
| 01/30/2007 | CA2440383C 7,9-substituted tetracycline compounds |
| 01/30/2007 | CA2228939C Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same |
| 01/30/2007 | CA2163747C Novel 1-phenylalkanone 5-ht4 receptor ligands |
| 01/30/2007 | CA2126917C New n-phenyl 2-cyano 3-hydroxy propenamides; tautomers and salts thereof; process for preparing them and their use as therapeutic agents; compositions containing these new product |
| 01/25/2007 | WO2007010990A1 Method of producing fullerene derivative |
| 01/25/2007 | WO2007009636A1 S-indacene and indeno[5,6-d][1,3]dioxol-derivatives and use thereof as components of liquid-crystal mixtures |
| 01/25/2007 | US20070021498 Novel tricyclic spiroderivatives as modulators of chemokine receptor activity |
| 01/25/2007 | US20070021494 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 01/25/2007 | DE102006032237A1 New s-indacen- and indeno(5,6-d)(1,3)dioxole derivatives useful in liquid crystalline medium, which is used as a dielectricum in electro optical display |
| 01/24/2007 | EP1745042A1 Diarylamine derivatives as calcium channel blockers |
| 01/24/2007 | EP0968206B8 N-heterocyclic derivatives as nos inhibitors |
| 01/24/2007 | CN1900067A Tricyclic compounds, their production and use |
| 01/23/2007 | US7166622 Administering substituted phenylsulfonamide for therapy and prophylaxis of Alzheimer's Disease and Down's syndrome |
| 01/23/2007 | US7166593 Glucocorticoid receptor modulators |
| 01/18/2007 | US20070015762 NPY Y5 antagonist |
| 01/18/2007 | US20070015755 Novel compounds and compositions as protease inhibitors |
| 01/18/2007 | US20070014822 2-[1-methyl-3-(2,6,6-trimethyl-1-cyclohexen-1-yl)allyl]-1,3-dioxolane; high stability, high strength, better lingering power; soaps, shower gels, shampoos, bath additives, skin creams, body lotions and deodorants, detergents; acetalization of 2-methyl-4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2-butenal |
| 01/18/2007 | CA2614930A1 Glutamate aggrecanase inhibitors |
| 01/17/2007 | EP1742927A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof |
| 01/17/2007 | EP1742905A2 Process of making alfa-aminooxyketone/ alfa-aminooxyaldehyde and alfa-hydroxyketone/ alfa-hydroxyaldehyde compounds and a process of making reaction products from cyclic alfa, beta-unsaturated ketone substrates and nitroso substrates |
| 01/17/2007 | EP1742904A2 Substituted enaminones, their derivatives and uses thereof |
| 01/17/2007 | EP1401575B1 Hydroxylation of beta-dicarbonyls with zirconium catalysts |
| 01/17/2007 | EP1173899A4 New electrolytes and lithium ion battery using the same |
| 01/17/2007 | CN1896064A Metabolites of ecteinascidin 743 |
| 01/11/2007 | WO2007004740A1 Vanillin acetals and sensory stimulant composition containing the same |
| 01/11/2007 | WO2006116007A3 Methods for synthesis of dicarbamate compounds and intermediates in the formation thereof |
| 01/11/2007 | WO2005092934A8 Orthoester-protected polyols for low voc coatings |
| 01/11/2007 | US20070010563 Novel methods for the treatment of inflammatory diseases |
| 01/11/2007 | US20070010453 Prodrugs of GABA analogs, compositions and uses thereof |
| 01/11/2007 | US20070010422 Improved bioavailability; for oral and intracolonic administration |
| 01/11/2007 | CA2614086A1 Vanillin acetals and sensory stimulant composition containing the same |
| 01/10/2007 | EP1740531A1 Indene derivatives and process for the preparation thereof |
| 01/10/2007 | EP1740523A1 New 1-methoxy-2-phenyl ethenes for the preparation of 5-carboxaldehyde-2-3-dihydrobenzoxepines |
| 01/10/2007 | EP1534699A4 Kinetic resolution method |
| 01/10/2007 | EP1066259B1 Biocidal benzylbiphenyl derivatives |
| 01/10/2007 | CN1894202A Benzoyl-substituted phenylalanine amides |
| 01/09/2007 | US7161022 Process for producing 4-phenyl-4-oxo-2-butenoic ester derivative |
| 01/09/2007 | US7160907 Pleuromutilin derivatives |
| 01/09/2007 | US7160903 Sulfonylaminocarboxylic acids |
| 01/04/2007 | WO2007001015A1 Process for production of optically active aminopentane derivative, intermediate in the process and process for production of the intermediate |
| 01/04/2007 | WO2005015158A3 T1r hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds |
| 01/04/2007 | US20070004806 Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors |
| 01/04/2007 | US20070004704 Such as 6-Methyl-2-[4-(5-methyl-2-phenyl-oxazol-4-ylmethoxy)-benzenesulfonylamino]-benzoic acid which binds Peroxisome Proliferator-Activated Receptors; conditions in which impaired glucose tolerance, hyperglycemia and insulin resistance are implicated, such as type-1 and type-2 diabetes, and Syndrome X |
| 01/04/2007 | US20070004698 specific activator of retinoic acid receptors subtype beta; 6-[3-adamantan-1-yl-4-(2,2-dimethyl[1,3]dioxoian-4-ylmethoxy)phenyl]naphthalene-2-carboxylic acid; useful in human or veterinary medicine; for body/hair hygiene, treating acne-prone skin, promoting hair regrowth, limiting hair loss, dry skin |
| 01/04/2007 | CA2612290A1 Process for preparing optically active aminopentane derivative, intermediate and process for preparing intermediate |
| 01/03/2007 | EP1737840A1 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof |
| 01/03/2007 | EP1737837A1 Method for producing optionally substituted methylenedioxybenzene |
| 01/03/2007 | EP1737813A1 Androgen modulators |
| 01/03/2007 | CN1293079C Method of producing high yield alditol acetals with mineral acids and surfactants |
| 01/03/2007 | CN1293047C Aminoacetonitriles derivant for controlling parasite |
| 01/02/2007 | US7157585 An aromatic alkylamino compound containing a lipophilic group useful as antithrombotic agent and for use in the treatment of mast cell mediated diseases such as asthma and other allergic and inflammatory conditions |
| 01/02/2007 | US7157489 HIV protease inhibitors |
| 01/02/2007 | US7157454 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 01/02/2007 | CA2235996C New compounds and their compositions having anti-inflammatory and anti-thrombotic activities |
| 12/28/2006 | WO2006136502A1 ( 6-FLU0R0-BENZ0[l, 3] DIOXOLYL) -MORPHOLIN-4-YL-METHANONES AND THEIR USE AS CBl LIGANDS |
| 12/28/2006 | WO2006135978A1 Antiviral compounds and methods |
| 12/28/2006 | US20060293536 via non-racemic cinchona-alkaloid-type catalyst (quinidine) for addition of nucleophile |
| 12/28/2006 | US20060293525 Optically active alpha-aminooxyketone derivatives and process for production thereof |
| 12/28/2006 | US20060293310 Derivatives of 1-piperazine-and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the FAAH enzyme |
| 12/28/2006 | CA2612403A1 Antiviral compounds and methods |
| 12/28/2006 | CA2612338A1 Sphingosine kinase inhibitors |
| 12/28/2006 | CA2612079A1 (6-flu0r0-benz0[1,3] dioxolyl)-morpholin-4-yl-methanones and their use as cb1 ligands |
| 12/27/2006 | EP1736465A1 Aniline derivatives |
| 12/27/2006 | EP1735280A1 Aryl sulfonamide and sulfonyl compounds as modulators of ppar and methods of treating metabolic disorders |
| 12/27/2006 | EP1734942A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors |
| 12/27/2006 | EP1358144B1 Epothilone synthesis components i: asymmetrically substituted acyloins and acyloin derivatives, method for the production thereof and method for the production of epithilone and epothilone derivatives |
| 12/27/2006 | EP1021410B1 Prostaglandin agonists and their use to treat bone disorders |
| 12/27/2006 | CN1886395A Method for producing glycerol carbonate methacrylate |
| 12/27/2006 | CN1886394A Process for the preparation of propylene carbonate |
| 12/27/2006 | CN1884280A Process for the preparation of piribedil |
| 12/27/2006 | CN1291989C Method for separating lycorine from plant extract |
| 12/26/2006 | US7153876 Malonamid and malonamic ester derivatives with antithrombotic activity, their preparation, and their use |
| 12/21/2006 | WO2006134955A1 1, 2-di(cyclic group)substituted benzene derivative |
| 12/21/2006 | US20060287298 Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 12/21/2006 | CA2607054A1 1, 2-di(cyclic group)substituted benzene derivative |
| 12/20/2006 | EP1734603A1 Electrolyte material for solid polymer type fuel cell, electrolyte membrane and membrane electrode assembly |
| 12/20/2006 | EP1732956A1 Orthoester-protected polyols for low voc coatings |
| 12/20/2006 | EP1732916A1 Chemical process |
| 12/20/2006 | EP1732884A1 Sulphonamide derivatives |